About Indigo Biosciences
Indigo Biosciences is a company based in State College (United States) founded in 2005.. Indigo Biosciences has raised $1.28 million across 4 funding rounds from investors including LSG Investments, Allied Growth Strategies & Management and iNetworks. The company has 17 employees as of December 31, 2023. Indigo Biosciences offers products and services including FGFR3 Reporter Assay Kit, DRD1 Reporter Assay Kit, GCGR Reporter Assay Kit, GIPR Reporter Assay Kit, and GLP-1R Reporter Assay Kit. Indigo Biosciences operates in a competitive market with competitors including Cellply, Lucid Scientific, Kiyatec, CytoTronics and Saguaro, among others.
- Headquarter State College, United States
- Employees 17 as on 31 Dec, 2023
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Indigo Biosciences, Incorporated
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$1.28 M (USD)
in 4 rounds
-
Latest Funding Round
$500 K (USD), Series B
Jun 28, 2016
-
Investors
LSG Investments
& 2 more
-
Employee Count
17
as on Dec 31, 2023
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Indigo Biosciences
Indigo Biosciences offers a comprehensive portfolio of products and services, including FGFR3 Reporter Assay Kit, DRD1 Reporter Assay Kit, GCGR Reporter Assay Kit, GIPR Reporter Assay Kit, and GLP-1R Reporter Assay Kit. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Kit for screening activity against Human Fibroblast Growth Factor Receptor.
Kit for screening activity against Human Dopamine Receptor D1.
Kit for screening activity against Human Glucagon Receptor.
Kit for screening activity against Human Gastric Inhibitory Polypeptide Receptor.
Kit for screening activity against Human Glucagon-Like Peptide-1 Receptor.
Unlock access to complete
Unlock access to complete
Leadership Team
8 people
Sales and Marketing
2 people
Scientist Team
2 people
CTO Team
1 people
Unlock access to complete
Funding Insights of Indigo Biosciences
Indigo Biosciences has successfully raised a total of $1.28M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $500 thousand completed in June 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series B — $500,000
-
First Round
First Round
(03 Sep 2010)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2016 | Amount | Series B - Indigo Biosciences | Valuation | LSGPA , Allied Growth Strategies & Management |
|
| Apr, 2014 | Amount | Series A - Indigo Biosciences | Valuation |
investors |
|
| Oct, 2011 | Amount | Seed - Indigo Biosciences | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Indigo Biosciences
Indigo Biosciences has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include LSG Investments, Allied Growth Strategies & Management and iNetworks. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage investments are made in life sciences technologies.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
iNetworks is engaged in private equity investments and operational support.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Indigo Biosciences
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Indigo Biosciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Indigo Biosciences Comparisons
Competitors of Indigo Biosciences
Indigo Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cellply, Lucid Scientific, Kiyatec, CytoTronics and Saguaro, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of in-vitro diagnostic products for the detection of cancer
|
|
| domain | founded_year | HQ Location |
Real-time cell analyzers are developed for oxygen consumption monitoring.
|
|
| domain | founded_year | HQ Location |
Kiyatec is focused on revolutionizing cancer care through predictive platforms.
|
|
| domain | founded_year | HQ Location |
Cell-based assays for drug discovery are developed via CMOS platform.
|
|
| domain | founded_year | HQ Location |
3D cell culture products are developed for drug discovery applications.
|
|
| domain | founded_year | HQ Location |
Metastatic cancer properties are targeted by Remedy Plan's containment therapy.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Indigo Biosciences
Frequently Asked Questions about Indigo Biosciences
When was Indigo Biosciences founded?
Indigo Biosciences was founded in 2005 and raised its 1st funding round 5 years after it was founded.
Where is Indigo Biosciences located?
Indigo Biosciences is headquartered in State College, United States. It is registered at State College, Pennsylvania, United States.
Is Indigo Biosciences a funded company?
Indigo Biosciences is a funded company, having raised a total of $1.28M across 4 funding rounds to date. The company's 1st funding round was a Seed of $682K, raised on Sep 03, 2010.
How many employees does Indigo Biosciences have?
As of Dec 31, 2023, the latest employee count at Indigo Biosciences is 17.
What does Indigo Biosciences do?
Founded in 2005 and based in State College, United States, Indigo Biosciences operates in the biotechnology sector. Nuclear receptor-specific reporter assays are developed using engineered cells preserved through the proprietary CryoMite process for extended storage and shipping. Cell-based assays for therapeutic drug target evaluation are offered, along with related in vitro toxicology services, enabling on-demand use in research applications.
Who are the top competitors of Indigo Biosciences?
Indigo Biosciences's top competitors include CytoTronics, Kiyatec and Remedy Plan.
What products or services does Indigo Biosciences offer?
Indigo Biosciences offers FGFR3 Reporter Assay Kit, DRD1 Reporter Assay Kit, GCGR Reporter Assay Kit, GIPR Reporter Assay Kit, and GLP-1R Reporter Assay Kit.
Who are Indigo Biosciences's investors?
Indigo Biosciences has 3 investors. Key investors include LSG Investments, Allied Growth Strategies & Management, and iNetworks.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.